Analyze the European, American and Asian Markets for Regenerative Medicine.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c53543) has announced the addition of Regenerative Medicine - Global Strategic Business Report to their offering.

This report analyzes the worldwide markets for Regenerative Medicine in Millions of US$. The report provides separate comprehensive analytics for the US, Japan, Europe, Canada, and Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2003 through 2010. The report profiles 107 companies including many key and niche players worldwide such as BioVest International, Inc., Celmed BioSciences, Curis, Inc., Cytori Therapeutics, Inc., DeveloGen AG, Geron Corporation, Human Genome Sciences, Inc., LifeCell Corporation, Osiris Therapeutics, Inc., Schering AG, Tepha Inc., Terumo Corporation, and TiGenix N.V. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Topics Covered
   I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  II. Executive Summary
   1. Industry Overview
   2. Product Overview
   3. Regulatory Environment
   4. Technological Innovations / Breakthroughs
   5. Recent Industry Activity
   6. Focus on Select Global Players
   7. Global Market Perspective

 III. MARKET
   1. The United States
   2. Japan
   3. Europe
   4. Review of Regenerative Medicine in Other Geographic Markets

  IV. COMPETITION

Companies Mentioned

- Aastrom Biosciences, Inc (USA) - ACell, Inc (USA) - Aderans Company Limited (Japan) - Advanced Cell Technology, Inc (USA) - Aldagen, Inc (USA) - ALTIS Biologics (Pty) Limited (South Africa) - Amniotec, Inc (Japan) - Athersys, Inc, (USA) - Baxter International, Inc (USA) - Bayer Schering Pharma AG (Germany) - Bioheart, Inc (USA) - BioHybrid Technologies, Inc (USA) - Biomimetic Therapeutics, Inc (USA) - Biostratum, Inc (USA) - Biosyntech, Inc (Canada) - BioVest International, Inc (USA) - Bone SA (South Africa) - Brainstorm Cell Therapeutics, Inc (USA) - Cambrex Corporation (USA) - Cardio, Inc (Japan) - CBR Systems, Inc (USA) - CellSeed, Inc (Japan) - CellTran Limited (UK) - Celmed Biosciences, Inc (Canada) - CoDon[R] AG (Germany) - Colbar Lifescience Ltd (Israel) - Cook Biotech, Inc (USA) - CordLife, Pte, Limited (Singapore) - Craveri (Argentina) - Cryocord (Malaysia) - Cryolife (USA) - Curasan AG (Germany) - Curis, Inc (USA) - Cytograft (USA) - Cytori Therapeutics, Inc (USA) - DeveloGen AG (Germany) - ES Cell International Pte, Ltd (Singapore) - Fibrogen, Inc (USA) - Fidia Advanced Biopolymers Srl (FAB) (Italy) - Fresenius Biotech GmbH (Germany) - Gambro AB (Sweden) - Genentech, Inc (USA) - Genzyme Corporation (USA) - Geron Corporation (USA) - GenVec, Inc (USA) - Gunze Ltd (Japan) - HealtheUniverse, Inc (USA) - Hitachi Medical Corporation (Japan) - Human Genome Sciences, Inc (USA) - Hydra Biosciences, Inc (USA) - Institute For Regenerative Medicine (USA) - Integra Lifesciences Holdings Corporation (USA) - Intercytex Ltd (UK) - Isolagen, Inc (USA) - Isotis BV (The Netherlands) - ISTO Technologies, Inc (USA) - Japan Tissue Engineering Co (Japan) - Johnson & Johnson (USA) - Kaken Pharmaceutical Co, Ltd (Japan) - Kirin Brewery Company  Limited (Japan) - Kuros Biosurgery AG (Switzerland) - Kyowa Hakko Kogyo Co, Ltd (Japan) - Laboratory For Regenerative Medicine & Pharmacobiology (LMRP) (Switzerland) - Lazaron Biotechnologies Stem Cell Bank (South Africa) - Lifecell Corporation (USA) - MAST Biosurgery AG (Switzerland) - McGowan Institute for Regenerative Medicine (USA) - MEBO International Group (China) - Millenium Biologix, Inc (Canada) - National Stem Cell, Inc (USA) - Nephrogen LLC (USA) - Neuronyx, Inc (USA) - Nichi-In Bio-Sciences Pvt, Ltd (India) - Olympus Corporation (Japan) - Olympus-Cytori, Inc (USA) - Organogenesis, Inc (USA) - Ortec International, Inc (USA) - Osiris Therapeutics, Inc (USA) - Prochon Biotech Ltd (Israel) - Proneuron Biotechnologies (USA) - Protein Polymer Technologies, Inc (USA) - Regen Biologics, Inc (USA) - Reliance Life Sciences (India) - ReNeuron Ltd (UK) - Revivicor, Inc (USA) - Rheogene, Inc (USA) - Riken Corporation (Japan) - Scil Proteins GmbH (Germany) - Selective Genetics (USA) - Smith & Nephew PLC (UK) - Stelic Institute & Company (Japan) - Stem Cell Sciences PLC (UK) - Stem Cell Therapeutics Corporation (Canada) - StemCells, Inc (USA) - Stemlife (Malaysia) - Stryker Corporation (USA) - TA Therapeutics Limited (Hong Kong) - TEI Biosciences, Inc (USA) - Tengion (USA) - Tepha, Inc (USA) - Terumo Corporation (Japan) - Theregen, Inc (USA) - Tigenix NV (Belgium) - Tissue Engineering, Inc (USA) - Tissue Genesis, Inc (USA) - TissueGene, Inc (USA) - Viacell, Inc (USA)

For more information visit http://www.researchandmarkets.com/reports/c53543